We are live on ! Find out more
NVCR icon

NovoCure
NVCR

356 hedge funds and large institutions have $12.9B invested in NovoCure in 2020 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 119 increasing their positions, 88 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 33

63% more call options, than puts

Call options by funds: $352M | Put options by funds: $215M

58% more capital invested

Capital invested by funds: $8.15B → $12.9B (+$4.71B)

35% more repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 88

26% more funds holding

Funds holding: 282 → 356 (+74)

0.45% more ownership

Funds ownership: 72.47% → 72.92% (+0.45%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
356
Holders Change
+74
Holders Change %
+26.24%
% of All Funds
6.3%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.14%
New
108
Increased
119
Reduced
88
Closed
33
Calls
$352M
Puts
$215M
Net Calls
+$136M
Net Calls Change
+$113M

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$153M
2
State Street
State Street
Massachusetts
+$107M
3
Victory Capital Management
Victory Capital Management
Texas
+$56M
4
EAM
Eagle Asset Management
Florida
+$38.2M
5
First Trust Advisors
First Trust Advisors
Illinois
+$36.7M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$93M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$84.9M
3
FCM
Farallon Capital Management
California
-$80.7M
4
DCP
Darsana Capital Partners
New York
-$78.7M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$45M
Name Holding Trade Value Shares
Change 		Change in
Stake
G
376
Gainplan
Michigan
– -$223K -2,000 Closed
WAM
377
Wolverine Asset Management
Illinois
– -$200K -1,798 Closed
EDRH
378
Edmond de Rothschild Holding
Switzerland
– -$111K -993 Closed
PGAM
379
Princeton Global Asset Management
New Jersey
– -$56K -500 Closed
GT
380
Glenmede Trust
Pennsylvania
– -$11K -100 Closed
RBC
381
Roble Belko & Company
Pennsylvania
– -$11K -100 Closed
FHA
382
Flagship Harbor Advisors
Massachusetts
– -$7K -70 Closed
GAM
383
Gemmer Asset Management
California
– -$6K -50 Closed
OIA
384
Optimum Investment Advisors
Illinois
– -$6K -50 Closed
SIM
385
Sonora Investment Management
Arizona
– -$3K -25 Closed
WEC
386
Winslow Evans & Crocker
Massachusetts
– -$2K -20 Closed
PFWA
387
Paces Ferry Wealth Advisors
Georgia
– -$1K -11 Closed
12 13 14 15
16

NVCR Hedge Fund Activity: Q4 2020 in Review

356 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2020, worth a combined $12.9B — up 58% from $8.15B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new NVCR positions and 33 closed out — a net gain of 75 holders — while 119 added to existing stakes and 88 trimmed.

The largest buyer was Capital World Investors, adding an estimated $153M. The largest seller was Renaissance Technologies, cutting an estimated $93M.

  • 356 institutional investors held NovoCure (NVCR) as of Q4 2020, up from 282 in Q3 2020.
  • Funds reported $12.9B of NovoCure stock for Q4 2020, up 58% quarter-over-quarter.
  • 108 funds opened new NovoCure positions in Q4 2020 and 33 closed out, a net change of +75 holders.
  • The largest NovoCure buyer in Q4 2020 was Capital World Investors, an estimated $153M added.
  • The largest NovoCure seller in Q4 2020 was Renaissance Technologies, an estimated $93M sold.

Based on aggregated 13F filings for Q4 2020.